1800343-11-6
1800343-11-6 structure
- Name: BET-IN-12
- Chemical Name: BET-IN-12
- CAS Number: 1800343-11-6
- Molecular Formula: C30H29D3FN5O2
- Molecular Weight: 516.62
- Catalog: Signaling Pathways Epigenetics Epigenetic Reader Domain
- Create Date: 2022-08-16 11:46:47
- Modify Date: 2024-01-09 17:48:53
-
BET-IN-12 is an orally avtive inhibitor of bromodomain and extra-terminal (BET) with an IC50 of 0.9 nM for BRD4[1].
| Name | BET-IN-12 |
|---|
| Description | BET-IN-12 is an orally avtive inhibitor of bromodomain and extra-terminal (BET) with an IC50 of 0.9 nM for BRD4[1]. |
|---|---|
| Related Catalog | |
| Target |
0.9 nM (BRD4)[1] |
| In Vitro | BET-IN-12 (compound 15) (24 hours) displays BRD4 and c-Myc inhibition, MM proliferation with IC50s values of 0.9 nM, 2.0 nM, and 6.0 nM, respectively[1]. BET-IN-12 (compound 15) (24 hours) has high oxidative stability across species and low glucuronidation across species, so that translate into low orally administered minimum efficacious doses (MEDs) [1]. |
| In Vivo | BET-IN-12 (compound 15) is 100% oral bioavailability in mouse[1]. BET-IN-12 (compound 15) impairs the growth of established PDX tumors (TGI = 88%) at MED = 2 mg/kg (AUC = 4800 nM•h)[1]. pharmacokinetic (PK) profile[1] dose (iv/po, mg/kg) CLp ((mL/min)/kg) Vd (L/kg) half-life (ie, h) F (%) AUC (po, nM.h) mouse 1.0/3.0 4.2 1.4 3.4 100 25000 rat 1.0/5.0 18 2.9 4.1 74 6600 dog 0.1/0.3 13 5.8 7.6 73 550 monkey 0.1/0.3 4.3 1.3 4.0 85 1900 |
| References |
| Molecular Formula | C30H29D3FN5O2 |
|---|---|
| Molecular Weight | 516.62 |